Squarepoint’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Squarepoint’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-13,233	Closed	-$165K	–	2197
2016 Q4	$165K	Buy	+13,233	New	+$159K	0.01%	1505
2016 Q3	–	Sell	-170,700	Closed	-$1.26M	–	1444
2016 Q2	$1.26M	Buy	170,700 +93,903	+122%	+$705K	0.08%	290
2016 Q1	$491K	Sell	76,797 -1,003	-1%	-$5.62K	0.04%	634
2015 Q4	$487K	Buy	+77,800	New	+$511K	0.05%	553

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Squarepoint's ARIA Position: Q1 2017 in Review

Squarepoint sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 13,233 shares — an estimated $165K sold.

Squarepoint first reported a position in ARIA in Q4 2015 and held it in 4 quarters. The position peaked at $1.26M in Q2 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Squarepoint reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Squarepoint sold 13,233 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $165K.
Squarepoint first reported a position in Ariad Pharmaceuticals Inc in Q4 2015 and held it in 4 quarters.
Squarepoint's Ariad Pharmaceuticals Inc position peaked at $1.26M in Q2 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Squarepoint's 13F filing for Q1 2017, filed 15 May 2017.